Stablecoin Development (SDEV) News
NYSE: SDEVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SDEV news summary
We found 4 recent headlines mentioning Stablecoin Development (SDEV): 1 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. SDEV is making an outsized move today, down 10.30% at $0.50, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "NovaBay Pharmaceuticals, Inc. Files Prospectus Supplement for Up to $100.0 million Additional ATM Shares", was published by Nasdaq on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Stablecoin Development headlines
- NovaBay Pharmaceuticals, Inc. Files Prospectus Supplement for Up to $100.0 million Additional ATM SharesNovaBay Pharmaceuticals, Inc. (filed under the name Stablecoin Development Corporation) reported that on November 17, 2026, it filed a prospectus supplement relating to the offer and sale of up to an…Nasdaq
- NovaBay Pharmaceuticals, Inc. Announces Voting Results of 2026 Annual Meeting of StockholdersNovaBay Pharmaceuticals, Inc., filing as Stablecoin Development Corporation, held its 2026 Annual Meeting of Stockholders on November 10, 2026. Out of 51,751,359 shares of the common stock, par value…NasdaqSDEV, HEI.A
- NovaBay Pharmaceuticals, Inc. Reports Third Quarter 2026 Financial ResultsNovaBay Pharmaceuticals, Inc. reported its financial results for the third quarter ended September 30, 2026. The company, which filed under the name Stablecoin Development Corporation, recorded…Nasdaq
- Stablecoin Development Corporation Reports Third Quarter 2026 Financial ResultsWEST PALM BEACH, Fla., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stablecoin Development Corporation (NYSE American: SDEV) (the “Company” or “SDEV”), an on-chain holding company focused on long-duration…GlobeNewswire